Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SALIM ORTIZ, JADIYI

NPI: 1831295310 · WHITE PLAINS, NY 10605 · Pediatrics Physician · NPI assigned 09/15/2006

$3.05M
Total Medicaid Paid
132,096
Total Claims
117,778
Beneficiaries
97
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 11,303 $378K
2019 18,429 $396K
2020 26,734 $422K
2021 22,152 $566K
2022 20,819 $549K
2023 19,594 $459K
2024 13,065 $278K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 17,407 15,582 $913K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,793 2,790 $311K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,519 2,392 $276K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,383 2,347 $271K
90460 Immunization administration through 18 years of age via any route, first or only component 9,047 8,811 $255K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1,650 1,591 $169K
G0270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes 7,063 6,877 $153K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,723 1,661 $141K
99442 1,676 1,608 $109K
92550 3,323 3,321 $74K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,585 1,541 $74K
92587 2,063 1,909 $46K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 1,615 1,548 $44K
83655 2,264 2,260 $30K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,902 946 $25K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,116 1,082 $24K
36410 1,231 1,207 $23K
99173 6,079 5,972 $16K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 137 137 $15K
0071A 245 244 $9K
0072A 241 240 $9K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 309 300 $6K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 1,280 1,260 $5K
36406 271 268 $5K
36415 Collection of venous blood by venipuncture 1,486 1,468 $4K
87110 629 612 $4K
97802 1,547 1,498 $4K
H0001 Alcohol and/or drug assessment 1,276 1,232 $4K
0001A 91 88 $3K
0002A 79 79 $3K
87081 646 637 $3K
96110 Developmental screening, with scoring and documentation, per standardized instrument 210 209 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 48 48 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 26 26 $2K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 37 37 $2K
99441 77 75 $2K
99443 22 21 $2K
92567 546 546 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 344 340 $1K
99382 12 12 $1K
0081A 18 16 $720.00
0082A 13 13 $520.00
90650 254 254 $453.03
J7030 Infusion, normal saline solution , 1000 cc 97 93 $415.71
99408 2,734 2,637 $198.64
90620 243 237 $175.64
4124F 16 16 $137.40
86580 13 13 $132.61
G8420 Bmi is documented within normal parameters and no follow-up plan is required 1,996 1,992 $111.15
90688 691 677 $48.09
91307 418 364 $19.82
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 48 47 $9.81
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram 15 15 $4.89
99080 9,422 799 $0.00
3016F 1,589 1,507 $0.00
90670 979 978 $0.00
G9820 Documentation of a chlamydia screening test with proper follow-up 1,102 1,101 $0.00
3725F 2,964 2,810 $0.00
90734 341 328 $0.00
90649 257 252 $0.00
90633 464 454 $0.00
G8482 Influenza immunization administered or previously received 192 192 $0.00
G9622 Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method 2,406 2,304 $0.00
90648 326 325 $0.00
G9821 No documentation of a chlamydia screening test with proper follow-up 206 206 $0.00
1159F 200 193 $0.00
90700 122 122 $0.00
90707 118 118 $0.00
90685 259 259 $0.00
91308 32 29 $0.00
90710 86 86 $0.00
90658 276 274 $0.00
91300 166 140 $0.00
90655 154 154 $0.00
90713 25 25 $0.00
90715 52 52 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 15 15 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 39 39 $0.00
90661 294 294 $0.00
1036F 2,345 2,212 $0.00
1000F 2,938 2,785 $0.00
2000F 2,394 2,294 $0.00
2010F 2,371 2,272 $0.00
G9275 Documentation that patient is a current non-tobacco user 2,940 2,793 $0.00
99000 14 14 $0.00
3008F 6,371 6,214 $0.00
90619 194 194 $0.00
2001F 2,385 2,287 $0.00
90716 129 129 $0.00
90680 315 315 $0.00
90686 3,691 3,666 $0.00
96127 180 163 $0.00
90744 12 12 $0.00
94760 67 66 $0.00
90698 58 58 $0.00
0001F 12 12 $0.00
90723 40 40 $0.00